Copyright: ©Author(s) 2026.
World J Nephrol. Jun 25, 2026; 15(2): 117719
Published online Jun 25, 2026. doi: 10.5527/wjn.v15.i2.117719
Published online Jun 25, 2026. doi: 10.5527/wjn.v15.i2.117719
Table 9 Anticipated future directions of artificial intelligence in chronic kidney disease care across time horizons
| Time horizon | Direction | Evidence base | Primary clinical impact |
| 5 years | Multimodal foundation models | Rapid growth in medical multimodal AI[125] | Improved calibration and consistency |
| Wearables and continuous monitoring | Digital CKD health reviews[126] | Earlier detection between visits | |
| PRO and text integration | 41% of CKD AI studies use unstructured data[7] | Patient-centered decision support | |
| ≥ 10 years | Digital twins | Early CKD prototype models[7] | In silico therapy planning |
| Multi-omics AI | Precision medicine frameworks[127] | Target discovery and stratification |
- Citation: Eskandar K. Artificial intelligence in chronic kidney disease: Early detection, risk prediction, and personalized treatment strategies. World J Nephrol 2026; 15(2): 117719
- URL: https://www.wjgnet.com/2220-6124/full/v15/i2/117719.htm
- DOI: https://dx.doi.org/10.5527/wjn.v15.i2.117719